Featured,Spotlight Stock,Trends & Articles Field Trip Health Enters Into a Partnership With Cerebral to Provide End-to-End Mental Health Care By Dennis Mutua March 04, 2022 Biotechnology company focusing on development and delivery of technology-enabled psychedelic therapies Field Trip Health Ltd. (NASDAQ: FTRP) (TSX: FTRP) has entered into a partnership with Cerebral to provide personalized end-to-e...
Featured,Spotlight Stock,Trends & Articles MindMed Releases Study Publication Showing Effects of LCD and Psilocybin on Health Participants By Dennis Mutua March 03, 2022 Biotechnology company developing psychedelic-inspired medicines and therapies to treat addiction and mental wellness Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) announced having released the publication of a study that compares ...
Featured,Spotlight Stock,Trends & Articles HAVN Life Granted Purchase Order for Controlled Substance Sale to Revive Therapeutics By Dennis Mutua February 28, 2022 Biotechnology company focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi HAVN Life Sciences Inc. (CSE: HAVN) (OTCMKTS: HAVLF) announced having secured a purchase order for natura...
Featured,Spotlight Stock,Trends & Articles Mydecine Approved by the FDA and DEA to Cultivate Psilocybin Mushrooms in the United States By Dennis Mutua February 24, 2022 Biotechnology company developing innovative first and second generation novel compounds therapeutics to treat addiction and mental health Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) has been granted approval by the U.S Foo...
Featured,Spotlight Stock,Trends & Articles Optimi Health Launches E-Commerce Platform Comprising All Natural Functional Mushroom Supplements By Dennis Mutua February 23, 2022 Biotechnology company developing integrated functional mushroom brand which focuses on health and wellness Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) has officially launched its line of functional mushroom supplements to consu...
Featured,Spotlight Stock,Trends & Articles Fun-Gal Snacks Introduces Crunchy Mushroom Chips By Dennis Mutua February 21, 2022 New York based company creating innovative snacks which harness the benefits of mushrooms and other underworld veggies Fun-Gal Snacks LLC has launched a flagship new crunchy mushroom chips dubbed ‘Popadelics’. The new vegan...
Featured,Spotlight Stock,Trends & Articles Nova Mentis Study Proves Oral Microdose Psilocybin Can Treat Autism By Dennis Mutua February 17, 2022 A study conducted by biotechnology company specializing on psilocybin based therapeutics and complementary diagnostics for neuroinflammatory disorders Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMLSF) has confirmed that an...
Featured,Spotlight Stock,Trends & Articles Fluence Raises $3 Million to Level Up Psychedelic Therapy Training By Dennis Mutua February 16, 2022 Educational platform focusing on training in psychedelic and psychedelic-assisted psychotherapy Fluence announced having raised $3 million from its just concluded seed funding round. Following this financing round the company h...